CVS Coram: Revolutionizing Pharmacy With Unmatched Convenience - test
Webin an effort to develop its specialty pharmacy business, cvs caremark (nyse:cvs) unveiled a $2. 1 billion deal on wednesday to acquire the specialty infusion.
Webcvs caremark corporation (nyse:cvs) recently completed the $2. 1 billion acquisition of drug infusion services provider coram llc.
Completed its $2. 1 billion acquisition of the drug infusion business coram llc, and it expects the deal to start helping earnings.
Recommended for you
Webdrugstore chain cvs caremark corp.
🔗 Related Articles You Might Like:
Celebrity Dirty Laundry: The Key To Understanding Recent Scandals! Exposed: The Secrets You Can't Miss! Job Seekers Delight Elk Grove Job Openings That Match Your Skills The Nexus Of Justice: Miami-Dade Clerk Of Courts, Connecting You To The Law📸 Image Gallery
You may also like